← Back to headlines
Nicox Sets April 2027 Regulatory Deadline for Glaucoma Drug NCX 470
Biotech firm Nicox has announced that the US FDA has scheduled a Prescription Drug User Fee Act (PDUFA) date of April 2027 for its novel glaucoma treatment, NCX 470.
27 Aug, 05:30 — 27 Aug, 05:30
Sources
Showing 1 of 1 sources



